Mineralys Therapeutics stock soars on positive hypertension trial results
-- Shares of Mineralys Therapeutics (NASDAQ:MLYS) surged 43% today following the announcement of positive topline results from its Launch-HTN and Advance-HTN trials...
-- Shares of Mineralys Therapeutics (NASDAQ:MLYS) surged 43% today following the announcement of positive topline results from its Launch-HTN and Advance-HTN trials...
(Reuters) - British shares fell on Monday as worries about global growth and uncertainties around U.S. tariffs continued to keep investors on edge. The blue-chip FTSE 100 lost...
-- Goldman Sachs analysts project that S&P 500 dividends will grow by 6% year-over-year in 2025, despite recent market volatility. “We forecast S&P 500 dividend...
-- Shares of Beam Therapeutics Inc. (Nasdaq: BEAM) surged 15% following the announcement of encouraging initial data from the Phase 1/2 trial of its BEAM-302...
-- U.S. stocks are more sensitive to changes in economic growth than to moves in Treasury yields, according to Lori Calvasina, head of U.S. equity strategy at RBC...
-- Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) surged 32% following the announcement of positive topline results from their Phase 2a RIVER trial of Haduvio. The...
LIVERPOOL, England (Reuters) - Liverpool have signed a multi-year kit deal with Adidas (OTC:ADDYY) beginning next season that will replace sportswear manufacturer Nike ...
-- Shares of Beacon (NASDAQ:BECN) surged 8% in pre-open trading Monday following the announcement of now 'friendly' discussions with QXO Inc (NYSE:QXO) about a...
-- Shares of Rocket Companies (NYSE:RKT) fell 7% today after the company announced its plans to acquire Redfin (NASDAQ:RDFN), which conversely saw its shares soar...
-- Air France-KLM has been downgraded by Bernstein to "market-perform" from "outperform," with a revised price target of €11.50. Shares of the airline were down 3.7%...